NLM Logo

trastuzumab deruxtecan MeSH Supplementary Concept Data 2024


MeSH Supplementary
trastuzumab deruxtecan
Unique ID
C000614160
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000614160
Entry Term(s)
DS-8201
DS-8201a
Registry Number
5384HK7574
Heading Mapped to
*Trastuzumab
Camptothecin / *analogs & derivatives
*Immunoconjugates
Frequency
108
Note
has both DNA topoisomerase I inhibitory and antineoplastic activities; consists of DX-8951 conjugated to a humanized antiā€HER2 antibody; structure in first source
Source
Cancer Sci. 2016 Jul;107(7):1039-46.
Date of Entry
2017/02/12
Revision Date
2020/08/24
trastuzumab deruxtecan Preferred
DS-8201a Narrower
page delivered in 0.004s